Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Barriers to and facilitators of participation of older adults in a placebo-controlled randomized clinical trial.

van de Glind EM, Vural EM, Scholten E, Hooft L, Portegijs E, van Munster BC, de Rooij SE.

J Am Geriatr Soc. 2013 Aug;61(8):1421-2. doi: 10.1111/jgs.12388. No abstract available.

PMID:
23937496
2.

The effects of melatonin versus placebo on delirium in hip fracture patients: study protocol of a randomised, placebo-controlled, double blind trial.

de Jonghe A, van Munster BC, van Oosten HE, Goslings JC, Kloen P, van Rees C, Wolvius R, van Velde R, Levi MM, Korevaar JC, de Rooij SE; Amsterdam Delirium Study group.

BMC Geriatr. 2011 Jul 5;11:34. doi: 10.1186/1471-2318-11-34.

3.

Effect of melatonin on incidence of delirium among patients with hip fracture: a multicentre, double-blind randomized controlled trial.

de Jonghe A, van Munster BC, Goslings JC, Kloen P, van Rees C, Wolvius R, van Velde R, Levi M, de Haan RJ, de Rooij SE; Amsterdam Delirium Study Group.

CMAJ. 2014 Oct 7;186(14):E547-56. doi: 10.1503/cmaj.140495. Epub 2014 Sep 2.

4.

Feasibility of family participation in a delirium prevention program for hospitalized older adults.

Rosenbloom-Brunton DA, Henneman EA, Inouye SK.

J Gerontol Nurs. 2010 Sep;36(9):22-33; quiz 34-5. doi: 10.3928/00989134-20100330-02. Epub 2010 Apr 22.

5.

Identifying motivations and barriers to patient participation in clinical trials.

Jones JM, Nyhof-Young J, Moric J, Friedman A, Wells W, Catton P.

J Cancer Educ. 2006 Winter;21(4):237-42.

PMID:
17542716
6.

Melatonin and melatonin agonist for delirium in the elderly patients.

Chakraborti D, Tampi DJ, Tampi RR.

Am J Alzheimers Dis Other Demen. 2015 Mar;30(2):119-29. doi: 10.1177/1533317514539379. Epub 2014 Jun 18. Review.

PMID:
24946785
7.

Melatonin treatment of day-night rhythm disturbances and sundowning in Alzheimer disease: an open-label pilot study using actigraphy.

Mahlberg R, Kunz D, Sutej I, Kühl KP, Hellweg R.

J Clin Psychopharmacol. 2004 Aug;24(4):456-9. No abstract available.

PMID:
15232344
8.

Why participate in an Alzheimer's disease clinical trial? Is it of benefit to carers and patients?

Mastwyk M, Macfarlane S, LoGiudice D, Sullivan KA.

Int Psychogeriatr. 2003 Jun;15(2):149-56.

PMID:
14620073
9.

Factors determining participation in prevention trials among systemic lupus erythematosus patients: a qualitative study.

Costenbader KH, Brome D, Blanch D, Gall V, Karlson E, Liang MH.

Arthritis Rheum. 2007 Feb 15;57(1):49-55.

10.

Carer impressions of participation in Alzheimer's disease clinical trials: what are their hopes? And is it worth it?

Mastwyk M, Ritchie CW, LoGiudice D, Sullivan KA, Macfarlane S.

Int Psychogeriatr. 2002 Mar;14(1):39-45.

PMID:
12094906
11.

[Use of procholinergics in the prevention of postoperative delirium in hip fracture surgery in the elderly. A randomized controlled trial].

Díaz V, Rodríguez J, Barrientos P, Serra M, Salinas H, Toledo C, Kunze S, Varas V, Santelices E, Cabrera C, Farías J, Gallardo J, Beddings MI, Leiva A, Cumsille MA.

Rev Neurol. 2001 Oct 16-31;33(8):716-9. Spanish.

12.

Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study.

Kalisvaart KJ, de Jonghe JF, Bogaards MJ, Vreeswijk R, Egberts TC, Burger BJ, Eikelenboom P, van Gool WA.

J Am Geriatr Soc. 2005 Oct;53(10):1658-66.

PMID:
16181163
13.

Demented patients' participation in a clinical trial: factors affecting the caregivers' decision.

Elad P, Treves TA, Drory M, Verchovsky R, Klimovitsky S, Ben-Laish S, Yaron S, Ginzburg K, Korczyn AD.

Int J Geriatr Psychiatry. 2000 Apr;15(4):325-30.

PMID:
10767732
14.

Methodological issues in the recruitment of cancer pain patients and their caregivers.

Ransom S, Azzarello LM, McMillan SC.

Res Nurs Health. 2006 Jun;29(3):190-8.

PMID:
16676340
15.

South Asian patients' views and experiences of clinical trial participation.

Hussain-Gambles M.

Fam Pract. 2004 Dec;21(6):636-42. Epub 2004 Nov 4.

16.

Glaucoma clinical trials.

Stewart WC, Stewart JA, Robin AL, Hennessy A, Sharpe ED.

Ophthalmology. 2010 Feb;117(2):397.e1-2. doi: 10.1016/j.ophtha.2009.11.009. No abstract available.

PMID:
20141854
17.

Post-study aspirin intake and factors motivating participation in a colorectal cancer chemoprevention trial.

Sample DA, Sinicrope PS, Wargovich MJ, Sinicrope FA.

Cancer Epidemiol Biomarkers Prev. 2002 Mar;11(3):281-5.

18.

[Attitudes of chronically-ill patients to telephone health coaching].

Seebauer L, Simon D, Bermejo I, Herbarth L, Siegmund-Schultze E, Temmert D, Schlegel D, Härter M.

Gesundheitswesen. 2011 Jul;73(7):430-7. doi: 10.1055/s-0030-1255082. Epub 2010 Jul 26. German.

PMID:
20661846
19.
20.

Motives for (not) participating in a lifestyle intervention trial.

Lakerveld J, Ijzelenberg W, van Tulder MW, Hellemans IM, Rauwerda JA, van Rossum AC, Seidell JC.

BMC Med Res Methodol. 2008 Apr 10;8:17. doi: 10.1186/1471-2288-8-17.

Items per page

Supplemental Content

Write to the Help Desk